The DOI matches its Crossref record; 141 of the 141 references it cites were found in a registry or an index.
Long Road to Ruin: Noradrenergic Dysfunction in Neurodegenerative Disease
Open accessAbstract
It has been known for decades that degeneration of the locus coeruleus (LC), the major noradrenergic nucleus in the brain, occurs in both Alzheimer’s disease (AD) and Parkinson’s disease (PD), but it was given scant attention. It is now recognized that hyperphosphorylated tau in the LC is the first detectable AD-like neuropathology in the human brain, α-synuclein inclusions in the LC represent an early step in PD, and experimental LC lesions exacerbate neuropathology and cognitive/behavioral deficits in animal models. The purpose of this review is to consider the causes and consequences of LC pathology, dysfunction, and degeneration, as well as their implications for early detection and treatment.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Neuropathological stageing of Alzheimer-related changes.
Braak, H., & Braak, E. (1991) · Acta Neuropathologica · doi:10.1007/bf00308809 · Cited by 16,123 · cited 1×
“According to the classic Braak AD staging paradigm, hyperphosphorylated or ‘pretangle’ forms of tau first appear in the transentorhinal cortex (Stages I–II), followed by their occurrence in the entorhinal cortex, hippocampus, and related temporal lobe structures (Stages III–IV), and finally in cortical regions in seve…”
Staging of brain pathology related to sporadic Parkinson’s disease
Braak, H., Tredici, K. D., Rüb, U., de Vos, R. A. I., Jansen Steur, E. N. H., & Braak, E. (2003) · Neurobiology of Aging · doi:10.1016/s0197-4580(02)00065-9 · Cited by 10,777 · cited 2×
“Braak staging of a-synuclein pathology revealed early involvement of the LC (Stage 2), prior to deposition in the dopaminergic substantia nigra (Stage 3) [32], and catastrophic LC cell loss is evident later in disease [1,14,44].”
Amyloid oligomers exacerbate tau pathology in a mouse model of tauopathy
Selenica, M.-L. B., Brownlow, M., Jimenez, J. P., Lee, D. C., Pena, G., Dickey, C. A., Gordon, M. N., & Morgan, D. (2013) · Neurodegenerative Diseases · doi:10.1159/000337230 · Cited by 10,359
THE CATECHOLAMINE HYPOTHESIS OF AFFECTIVE DISORDERS: A REVIEW OF SUPPORTING EVIDENCE
SCHILDKRAUT, J. J. (1965) · American Journal of Psychiatry · doi:10.1176/ajp.122.5.509 · Cited by 3,492
Berridge, C. W., & Waterhouse, B. D. (2003) · Brain Research Reviews · doi:10.1016/s0165-0173(03)00143-7 · Cited by 2,529 · cited 3×
“Many LC axons are thin, highly arborized, unmyelinated, and among the longest in the brain, potentially making them particularly fragile [133] (although conduction velocity evidence suggests existence of some myelinated LC axons in non-human primates) [138].”
InfluentialSynapse Loss and Microglial Activation Precede Tangles in a P301S Tauopathy Mouse Model
Yoshiyama, Y., Higuchi, M., Zhang, B., Huang, S.-M., Iwata, N., Saido, T. C., Maeda, J., Suhara, T., Trojanowski, J. Q., & Lee, V. M.-Y. (2007) · Neuron · doi:10.1016/j.neuron.2007.01.010 · Cited by 2,208
Stages of the Pathologic Process in Alzheimer Disease: Age Categories From 1 to 100 Years
Braak, H., Thal, D. R., Ghebremedhin, E., & Del Tredici, K. (2011) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e318232a379 · Cited by 2,194
Non-motor features of Parkinson disease
Schapira, A. H. V., Chaudhuri, K. R., & Jenner, P. (2017) · Nature Reviews Neuroscience · doi:10.1038/nrn.2017.62 · Cited by 2,053
Aston-Jones, G., & Bloom, F. (1981) · The Journal of Neuroscience · doi:10.1523/jneurosci.01-08-00876.1981 · Cited by 1,960 · cited 1×
“Importantly, changes in LC firing precede sleep–wake transitions, and optogenetic or chemogenetic activation of the LC induces wakefulness, suggesting a causative rather than responsive role [71,90,91].”
The locus coeruleus and noradrenergic modulation of cognition
Sara, S. J. (2009) · Nature Reviews Neuroscience · doi:10.1038/nrn2573 · Cited by 1,848
The many faces of α-synuclein: from structure and toxicity to therapeutic target
Lashuel, H. A., Overk, C. R., Oueslati, A., & Masliah, E. (2013) · Nature Reviews Neuroscience · doi:10.1038/nrn3406 · Cited by 1,622
Norepinephrine in Depressive Reactions: A Review
BUNNEY, W. E. (1965) · Archives of General Psychiatry · doi:10.1001/archpsyc.1965.01730060001001 · Cited by 1,153
Conner, J. M., Lauterborn, J. C., Yan, Q., Gall, C. M., & Varon, S. (1997) · The Journal of Neuroscience · doi:10.1523/jneurosci.17-07-02295.1997 · Cited by 1,097 · cited 3×
“Besides NE, LC neurons produce a host of other small molecule and peptide neuromodulators including ATP [114], galanin [117,118], neuropeptide Y [117], enkephalin [119], cocaine- and amphetamine-regulated transcript [120], and brain-derived neurotrophic factor (BDNF) [121,122].”
Clinical progression in Parkinson disease and the neurobiology of axons
Cheng, H., Ulane, C. M., & Burke, R. E. (2010) · Annals of Neurology · doi:10.1002/ana.21995 · Cited by 1,012 · cited 1×
“This pattern is consistent with dopaminergic degeneration in clinical and experimental PD, where imaging studies reveal DA axon loss prior to cell body degeneration [57], striatal DA loss ( 80%) is greater than death of DA neurons in the substantia nigra ( 50%) [58], and Thy1-Syn transgenicmice show progressive reduct…”
Zarow, C., Lyness, S. A., Mortimer, J. A., & Chui, H. C. (2003) · Archives of Neurology · doi:10.1001/archneur.60.3.337 · Cited by 1,002
Tuning arousal with optogenetic modulation of locus coeruleus neurons
Carter, M. E., Yizhar, O., Chikahisa, S., Nguyen, H., Adamantidis, A., Nishino, S., Deisseroth, K., & de Lecea, L. (2010) · Nature Neuroscience · doi:10.1038/nn.2682 · Cited by 993
Foote, S. L., Aston-Jones, G., & Bloom, F. E. (1980) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.77.5.3033 · Cited by 857
Neuronal activity enhances tau propagation and tau pathology in vivo
Wu, J. W., Hussaini, S. A., Bastille, I. M., Rodriguez, G. A., Mrejeru, A., Rilett, K., Sanders, D. W., Cook, C., Fu, H., Boonen, R. A. C. M., et al. (2016) · Nature Neuroscience · doi:10.1038/nn.4328 · Cited by 820
The pathological process underlying Alzheimer’s disease in individuals under thirty
Braak, H., & Del Tredici, K. (2011) · Acta Neuropathologica · doi:10.1007/s00401-010-0789-4 · Cited by 812
Where Does Parkinson Disease Pathology Begin in the Brain?
Del Tredici, K., Rüb, U., de Vos, R. A. I., Bohl, J. R. E., & Braak, H. (2002) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/61.5.413 · Cited by 773
Olfactory dysfunction in Parkinson disease
Doty, R. L. (2012) · Nature Reviews Neurology · doi:10.1038/nrneurol.2012.80 · Cited by 737
Bondareff, W., Mountjoy, C. Q., & Roth, M. (1982) · Neurology · doi:10.1212/wnl.32.2.164 · Cited by 680
CRH Engagement of the Locus Coeruleus Noradrenergic System Mediates Stress-Induced Anxiety
McCall, J. G., Al-Hasani, R., Siuda, E. R., Hong, D. Y., Norris, A. J., Ford, C. P., & Bruchas, M. R. (2015) · Neuron · doi:10.1016/j.neuron.2015.07.002 · Cited by 666
Pathogenic protein seeding in Alzheimer disease and other neurodegenerative disorders
Jucker, M., & Walker, L. C. (2011) · Annals of Neurology · doi:10.1002/ana.22615 · Cited by 622 · cited 1×
“The ‘seeding’ hypothesis refers to the idea that misfolded proteins originate in one population of neurons, and then spread pathology to interconnected brain regions via a prionlike process of corruptive templating [105].”
Noradrenergic mechanisms in stress and anxiety: I. preclinical studies
Bremner, J. D., Krystal, J. H., Southwick, S. M., & Charney, D. S. (1996) · Synapse · doi:10.1002/(sici)1098-2396(199605)23:1<28::aid-syn4>3.0.co;2-j · Cited by 594
Biochemical aspects of Parkinson's disease
Hornykiewicz, O. (1998) · Neurology · doi:10.1212/wnl.51.2_suppl_2.s2 · Cited by 564
Pasanen, P., Myllykangas, L., Siitonen, M., Raunio, A., Kaakkola, S., Lyytinen, J., Tienari, P. J., Pöyhönen, M., & Paetau, A. (2014) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2014.03.024 · Cited by 536
Sleep, circadian rhythms, and the pathogenesis of Alzheimer disease
Musiek, E. S., Xiong, D. D., & Holtzman, D. M. (2015) · Experimental & Molecular Medicine · doi:10.1038/emm.2014.121 · Cited by 529
Disease‐specific patterns of locus coeruleus cell loss
German, D. C., Manaye, K. F., White, C. L., Woodward, D. J., McIntire, D. D., Smith, W. K., Kalaria, R. N., & Mann, D. M. A. (1992) · Annals of Neurology · doi:10.1002/ana.410320510 · Cited by 512
Chan‐Palay, V., & Asan, E. (1989) · Journal of Comparative Neurology · doi:10.1002/cne.902870308 · Cited by 495
The Locus Coeruleus: Essential for Maintaining Cognitive Function and the Aging Brain
Mather, M., & Harley, C. W. (2016) · Trends in Cognitive Sciences · doi:10.1016/j.tics.2016.01.001 · Cited by 492
Changes in the Brain Catecholamines in Patients with Dementia of Alzheimer Type
Adolfsson, R., Gottfries, C. G., Roos, B. E., & Winblad, B. (1979) · British Journal of Psychiatry · doi:10.1192/bjp.135.3.216 · Cited by 449
Theofilas, P., Ehrenberg, A. J., Dunlop, S., Di Lorenzo Alho, A. T., Nguy, A., Leite, R. E. P., Rodriguez, R. D., Mejia, M. B., Suemoto, C. K., Ferretti-Rebustini, R. E. D. L., et al. (2017) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2016.06.2362 · Cited by 416
Grudzien, A., Shaw, P., Weintraub, S., Bigio, E., Mash, D. C., & Mesulam, M. M. (2007) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2006.02.007 · Cited by 396
Braak, H., & Del Tredici, K. (2017) · Journal of Parkinson’s Disease · doi:10.3233/jpd-179001 · Cited by 372 · cited 1×
“Moreover, degeneration of the LC and noradrenergic inputs to the cortex appear to bemore severe in PD patients with dementia compared to thosewithout cognitive impairment [31,69].”
Alzheimer’s pathogenesis: is there neuron-to-neuron propagation?
Braak, H., & Del Tredici, K. (2011) · Acta Neuropathologica · doi:10.1007/s00401-011-0825-z · Cited by 359
A Progressive Mouse Model of Parkinson’s Disease: The Thy1-aSyn (“Line 61”) Mice
Chesselet, M.-F., Richter, F., Zhu, C., Magen, I., Watson, M. B., & Subramaniam, S. R. (2012) · Neurotherapeutics · doi:10.1007/s13311-012-0104-2 · Cited by 346
Tofaris, G. K., Garcia Reitböck, P., Humby, T., Lambourne, S. L., O’Connell, M., Ghetti, B., Gossage, H., Emson, P. C., Wilkinson, L. S., Goedert, M., et al. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.4965-05.2006 · Cited by 326
Role of norepinephrine in the pathophysiology and treatment of mood disorders
Ressler, K. J., & Nemeroff, C. B. (1999) · Biological Psychiatry · doi:10.1016/s0006-3223(99)00127-4 · Cited by 307
The Brainstem Pathologies of Parkinson's Disease and Dementia with Lewy Bodies
Seidel, K., Mahlke, J., Siswanto, S., Krüger, R., Heinsen, H., Auburger, G., Bouzrou, M., Grinberg, L. T., Wicht, H., Korf, H., et al. (2015) · Brain Pathology · doi:10.1111/bpa.12168 · Cited by 306
Heneka, M. T., Ramanathan, M., Jacobs, A. H., Dumitrescu-Ozimek, L., Bilkei-Gorzo, A., Debeir, T., Sastre, M., Galldiks, N., Zimmer, A., Hoehn, M., et al. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.4236-05.2006 · Cited by 305
Grenhoff, J., Nisell, M., Ferr�, S., Aston-Jones, G., & Svensson, T. H. (1993) · Journal of Neural Transmission · doi:10.1007/bf01244934 · Cited by 292
Locus coeruleus cellular and molecular pathology during the progression of Alzheimer’s disease
Kelly, S. C., He, B., Perez, S. E., Ginsberg, S. D., Mufson, E. J., & Counts, S. E. (2017) · Acta Neuropathologica Communications · doi:10.1186/s40478-017-0411-2 · Cited by 286
Changes in the Monoamine Containing Neurones of the Human Cns in Senile Dementia
Mann, D. M. A., Lincoln, J., Yates, P. O., Stamp, J. E., & Toper, S. (1980) · British Journal of Psychiatry · doi:10.1192/bjp.136.6.533 · Cited by 285
Vazey, E. M., & Aston-Jones, G. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1310025111 · Cited by 279
Neural reserve, neuronal density in the locus ceruleus, and cognitive decline
Wilson, R. S., Nag, S., Boyle, P. A., Hizel, L. P., Yu, L., Buchman, A. S., Schneider, J. A., & Bennett, D. A. (2013) · Neurology · doi:10.1212/wnl.0b013e3182897103 · Cited by 274
α-Synuclein promotes dilation of the exocytotic fusion pore
Logan, T., Bendor, J., Toupin, C., Thorn, K., & Edwards, R. H. (2017) · Nature Neuroscience · doi:10.1038/nn.4529 · Cited by 267
Where, when, and in what form does sporadic Alzheimerʼs disease begin?
Braak, H., & Del Tredici, K. (2012) · Current Opinion in Neurology · doi:10.1097/wco.0b013e32835a3432 · Cited by 257
Norepinephrine: The redheaded stepchild of Parkinson's disease
Rommelfanger, K. S., & Weinshenker, D. (2007) · Biochemical Pharmacology · doi:10.1016/j.bcp.2007.01.036 · Cited by 255
Self-citationCaudo‐rostral brain spreading of α‐synuclein through vagal connections
Ulusoy, A., Rusconi, R., Pérez‐Revuelta, B. I., Musgrove, R. E., Helwig, M., Winzen‐Reichert, B., & Monte, D. A. D. (2013) · EMBO Molecular Medicine · doi:10.1002/emmm.201302475 · Cited by 250
Szot, P., White, S. S., Greenup, J. L., Leverenz, J. B., Peskind, E. R., & Raskind, M. A. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.4265-05.2006 · Cited by 248
Del Tredici, K., & Braak, H. (2013) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp-2011-301817 · Cited by 236
Ehrenberg, A. J., Nguy, A. K., Theofilas, P., Dunlop, S., Suemoto, C. K., Di Lorenzo Alho, A. T., Leite, R. P., Diehl Rodriguez, R., Mejia, M. B., Rüb, U., et al. (2017) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12387 · Cited by 236
Norepinephrine deficiency in Parkinson's disease: The case for noradrenergic enhancement
Espay, A. J., LeWitt, P. A., & Kaufmann, H. (2014) · Movement Disorders · doi:10.1002/mds.26048 · Cited by 234
Noradrenaline and Parkinson's Disease
Delaville, C., Deurwaerdère, P. D., & Benazzouz, A. (2011) · Frontiers in Systems Neuroscience · doi:10.3389/fnsys.2011.00031 · Cited by 228
Rorabaugh, J. M., Chalermpalanupap, T., Botz-Zapp, C. A., Fu, V. M., Lembeck, N. A., Cohen, R. M., & Weinshenker, D. (2017) · Brain · doi:10.1093/brain/awx232 · Cited by 227 · cited 6×
“, chemogenetic/optogenetic facilitation, NE prodrugs/agonists/reuptake inhibitors, aerobic exercise, environmental enrichment) could be of benefit, as already shown for animal models and in some human studies [16,17,21,30,42,130,131].”
InfluentialSelf-citationClewett, D. V., Lee, T.-H., Greening, S., Ponzio, A., Margalit, E., & Mather, M. (2016) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2015.09.019 · Cited by 226
Iba, M., McBride, J. D., Guo, J. L., Zhang, B., Trojanowski, J. Q., & Lee, V. M.-Y. (2015) · Acta Neuropathologica · doi:10.1007/s00401-015-1458-4 · Cited by 223
Trillo, L., Das, D., Hsieh, W., Medina, B., Moghadam, S., Lin, B., Dang, V., Sanchez, M. M., De Miguel, Z., Ashford, J. W., et al. (2013) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2013.05.008 · Cited by 221
Pinton, S., Sampaio, T., Savall, A., & Gutierrez, M. Z. (2017) · Neural Regeneration Research · doi:10.4103/1673-5374.205084 · Cited by 219
Dopamine induces soluble α-synuclein oligomers and nigrostriatal degeneration
Mor, D. E., Tsika, E., Mazzulli, J. R., Gould, N. S., Kim, H., Daniels, M. J., Doshi, S., Gupta, P., Grossman, J. L., Tan, V. X., et al. (2017) · Nature Neuroscience · doi:10.1038/nn.4641 · Cited by 217
Are tau aggregates toxic or protective in tauopathies?
Cowan, C. M., & Mudher, A. (2013) · Frontiers in Neurology · doi:10.3389/fneur.2013.00114 · Cited by 215
Benarroch, E. E. (2018) · Cell and Tissue Research · doi:10.1007/s00441-017-2649-1 · Cited by 215
Noradrenergic changes, aggressive behavior, and cognition in patients with dementia
Matthews, K. L., Chen, C. P. L.-H., Esiri, M. M., Keene, J., Minger, S. L., & Francis, P. T. (2002) · Biological Psychiatry · doi:10.1016/s0006-3223(01)01235-5 · Cited by 211
Wang, L. Y., Shofer, J. B., Rohde, K., Hart, K. L., Hoff, D. J., McFall, Y. H., Raskind, M. A., & Peskind, E. R. (2009) · The American Journal of Geriatric Psychiatry · doi:10.1097/jgp.0b013e3181ab8c61 · Cited by 209
Deep clinical and neuropathological phenotyping of Pick disease
Irwin, D. J., Brettschneider, J., McMillan, C. T., Cooper, F., Olm, C., Arnold, S. E., Van Deerlin, V. M., Seeley, W. W., Miller, B. L., Lee, E. B., et al. (2016) · Annals of Neurology · doi:10.1002/ana.24559 · Cited by 204
Kalinin, S., Gavrilyuk, V., Polak, P. E., Vasser, R., Zhao, J., Heneka, M. T., & Feinstein, D. L. (2007) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2006.06.003 · Cited by 200
Early neurone loss in Alzheimer’s disease: cortical or subcortical?
Arendt, T., Brückner, M. K., Morawski, M., Jäger, C., & Gertz, H.-J. (2015) · Acta Neuropathologica Communications · doi:10.1186/s40478-015-0187-1 · Cited by 197
Synchronous Activity in Locus Coeruleus Results from Dendritic Interactions in Pericoerulear Regions
Ishimatsu, M., & Williams, J. T. (1996) · The Journal of Neuroscience · doi:10.1523/jneurosci.16-16-05196.1996 · Cited by 191
McMorris, T. (2016) · Physiology & Behavior · doi:10.1016/j.physbeh.2016.08.011 · Cited by 188 · cited 1×
“, chemogenetic/optogenetic facilitation, NE prodrugs/agonists/reuptake inhibitors, aerobic exercise, environmental enrichment) could be of benefit, as already shown for animal models and in some human studies [16,17,21,30,42,130,131].”
Parkinson's Disease Is Not Simply a Prion Disorder
Surmeier, D. J., Obeso, J. A., & Halliday, G. M. (2017) · The Journal of Neuroscience · doi:10.1523/jneurosci.1787-16.2017 · Cited by 188
Steenland, K., Karnes, C., Seals, R., Carnevale, C., Hermida, A., & Levey, A. (2012) · Journal of Alzheimer's Disease · doi:10.3233/jad-2012-111922 · Cited by 187
Xu, Z.-Q. D., Shi, T.-J. S., & H�kfelt, T. (1998) · The Journal of Comparative Neurology · doi:10.1002/(sici)1096-9861(19980309)392:2<227::aid-cne6>3.0.co;2-4 · Cited by 186
Monoaminergic innervation of the frontal and temporal lobes in Alzheimer's disease
Palmer, A. M., Wilcock, G. K., Esiri, M. M., Francis, P. T., & Bowen, D. M. (1987) · Brain Research · doi:10.1016/0006-8993(87)91408-9 · Cited by 186
Norepinephrine loss produces more profound motor deficits than MPTP treatment in mice
Rommelfanger, K. S., Edwards, G. L., Freeman, K. G., Liles, L. C., Miller, G. W., & Weinshenker, D. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0702753104 · Cited by 184
Self-citationFunctional Consequences of Locus Coeruleus Degeneration in Alzheimers Disease
Weinshenker, D. (2008) · Current Alzheimer Research · doi:10.2174/156720508784533286 · Cited by 181
Self-citationPrecortical Phase of Alzheimer's Disease (AD)‐Related Tau Cytoskeletal Pathology
Stratmann, K., Heinsen, H., Korf, H., Del Turco, D., Ghebremedhin, E., Seidel, K., Bouzrou, M., Grinberg, L. T., Bohl, J., Wharton, S. B., et al. (2016) · Brain Pathology · doi:10.1111/bpa.12289 · Cited by 173
Mitochondrial oxidant stress in locus coeruleus is regulated by activity and nitric oxide synthase
Sanchez-Padilla, J., Guzman, J. N., Ilijic, E., Kondapalli, J., Galtieri, D. J., Yang, B., Schieber, S., Oertel, W., Wokosin, D., Schumacker, P. T., et al. (2014) · Nature Neuroscience · doi:10.1038/nn.3717 · Cited by 172
The Role of the Tripartite Glutamatergic Synapse in the Pathophysiology of Alzheimer’s Disease
Rudy, C. C., Hunsberger, H. C., Weitzner, D. S., & Reed, M. N. (2015) · Aging and disease · doi:10.14336/ad.2014.0423 · Cited by 171
Castren, E., Thoenen, H., & Lindholm, D. (1995) · Neuroscience · doi:10.1016/0306-4522(94)00386-j · Cited by 169
Noradrenaline activation of neurotrophic pathways protects against neuronal amyloid toxicity
Counts, S., & Mufson, E. J. (2010) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2010.06622.x · Cited by 167
PATHOLOGICAL BASIS FOR NEUROTRANSMITTER CHANGES IN PARKINSON'S DISEASE
MANN, D. M. A., & YATES, P. O. (1983) · Neuropathology and Applied Neurobiology · doi:10.1111/j.1365-2990.1983.tb00320.x · Cited by 164
Magnetic resonance imaging of the human locus coeruleus: A systematic review
Liu, K. Y., Marijatta, F., Hämmerer, D., Acosta-Cabronero, J., Düzel, E., & Howard, R. J. (2017) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2017.10.023 · Cited by 161
Crimins, J. L., Rocher, A. B., & Luebke, J. I. (2012) · Acta Neuropathologica · doi:10.1007/s00401-012-1038-9 · Cited by 153
Elevated Tyrosine Hydroxylase in the Locus Coeruleus of Suicide Victims
Ordway, G. A., Smith, K. S., & Haycock, J. W. (1994) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1994.62020680.x · Cited by 152
Poe, G. R. (2017) · Journal of Neuroscience · doi:10.1523/jneurosci.0820-16.2017 · Cited by 151
Targeting norepinephrine in mild cognitive impairment and Alzheimer's disease
Chalermpalanupap, T., Kinkead, B. L., Hu, W. T., Kummer, M. P., Hammerschmidt, T., Heneka, M. T., Weinshenker, D., & Levey, A. I. (2013) · Alzheimer s Research & Therapy · doi:10.1186/alzrt175 · Cited by 150
Self-citationJardanhazi‐Kurutz, D., Kummer, M. P., Terwel, D., Vogel, K., Dyrks, T., Thiele, A., & Heneka, M. T. (2010) · Neurochemistry International · doi:10.1016/j.neuint.2010.02.001 · Cited by 145
Chalermpalanupap, T., Schroeder, J. P., Rorabaugh, J. M., Liles, L. C., Lah, J. J., Levey, A. I., & Weinshenker, D. (2018) · The Journal of Neuroscience · doi:10.1523/jneurosci.1483-17.2017 · Cited by 136 · cited 3×
“Indeed, neurotoxic lesions of the LC or genetic NE depletion exacerbates learning and memory deficits in several rodentmodels ofADandPD [16–18,20,21,63], andweandothershave recently extended this finding toclinical populationsand tau-basedmodels [38,41].”
Self-citationCatecholaminergic neurones assessed ante-mortem in Alzheimer's disease
Palmer, A. M., Francis, P. T., Bowen, D. M., Benton, J. S., Neary, D., Mann, D. M. A., & Snowden, J. S. (1987) · Brain Research · doi:10.1016/0006-8993(87)90018-7 · Cited by 135
The topography of cell loss from locus caeruleus in Alzheimer's disease
Marcyniuk, B., Mann, D. M. A., & Yates, P. O. (1986) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(86)90179-6 · Cited by 135
Vermeiren, Y., & Deyn, P. P. D. (2016) · Neurochemistry International · doi:10.1016/j.neuint.2016.11.009 · Cited by 134
The Role of Norepinephrine in the Behavioral and Psychological Symptoms of Dementia
Herrmann, N., Lanctôt, K. L., & Khan, L. R. (2004) · Journal of Neuropsychiatry · doi:10.1176/jnp.16.3.261 · Cited by 132
The emerging role of norepinephrine in cognitive dysfunctions of Parkinson's disease
Vazey, E. M., & Aston‐Jones, G. (2012) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2012.00048 · Cited by 131
Schank, J. R., Ventura, R., Puglisi‐Allegra, S., Alcaro, A., Cole, C. D., Liles, L. C., Seeman, P. M., & Weinshenker, D. (2005) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301000 · Cited by 129
Self-citationSmall-molecule PET Tracers for Imaging Proteinopathies
Mathis, C. A., Lopresti, B. J., Ikonomović, M. D., & Klunk, W. E. (2017) · Seminars in Nuclear Medicine · doi:10.1053/j.semnuclmed.2017.06.003 · Cited by 128
Theofilas, P., Dunlop, S. R., Heinsen, H., & Grinberg, L. T. (2015) · Journal of Alzheimer s Disease · doi:10.3233/jad-142682 · Cited by 126
Hansen, N. (2017) · Neural Plasticity · doi:10.1155/2017/2727602 · Cited by 123
Hammerschmidt, T., Kummer, M. P., Terwel, D., Martinez, A., Gorji, A., Pape, H., Rommelfanger, K. S., Schroeder, J. P., Stoll, M., Schultze, J. L., et al. (2012) · Biological Psychiatry · doi:10.1016/j.biopsych.2012.06.013 · Cited by 121
Self-citationLocus coeruleus at asymptomatic early and middle Braak stages of neurofibrillary tangle pathology
Andrés‐Benito, P., Fernández‐Dueñas, V., Carmona, M., Escobar, L. A., Torrejón-Escribano, B., Aso, E., Ciruela, F., & Ferrer, I. (2017) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12386 · Cited by 120
McMillan, P. J., White, S. S., Franklin, A., Greenup, J. L., Leverenz, J. B., Raskind, M. A., & Szot, P. (2010) · Brain Research · doi:10.1016/j.brainres.2010.12.015 · Cited by 119
The noradrenaline precursor L-DOPS reduces pathology in a mouse model of Alzheimer’s disease
Kalinin, S., Polak, P. E., Lin, S. X., Sakharkar, A. J., Pandey, S. C., & Feinstein, D. L. (2012) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2011.04.012 · Cited by 116
Altered activity of the locus coeruleus in an animal model of depression.
Simson, P. E., & Weiss, J. M. (1988) · PubMed · Cited by 113
Frequency-dependent synchrony in locus ceruleus: Role of electrotonic coupling
Alvarez, V. A., Chow, C. C., Bockstaele, E. J. V., & Williams, J. T. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.062716299 · Cited by 112
Spatial, Temporal and Numeric Analysis of Alzheimer Changes in the Nucleus Coeruleus
Busch, C., Bohl, J. R. E., & Ohm, T. G. (1997) · Neurobiology of Aging · doi:10.1016/s0197-4580(97)00035-3 · Cited by 105
Noradrenaline in Parkinsons Disease: From Disease Progression to Current Therapeutics
Fornai, F., di Poggio, A. B., Pellegrini, A., Ruggieri, S. A., & Paparelli, A. (2007) · Current Medicinal Chemistry · doi:10.2174/092986707781745550 · Cited by 103
Whole-Brain Mapping of Neuronal Activity in the Learned Helplessness Model of Depression
Kim, Y., Perova, Z., Mirrione, M. M., Pradhan, K., Henn, F. A., Shea, S. D., Osten, P., & Li, B. (2016) · Frontiers in Neural Circuits · doi:10.3389/fncir.2016.00003 · Cited by 102
Hyperphosphorylated tau in young and middle-aged subjects
El‐Obeid, A., Soininen, H. S., & Alafuzoff, I. I. (2011) · Acta Neuropathologica · doi:10.1007/s00401-011-0906-z · Cited by 95
Hunsley, M. S., & Palmiter, R. D. (2003) · SLEEP · doi:10.1093/sleep/26.5.521 · Cited by 92
Relevance of parahippocampal-locus coeruleus connectivity to memory in early dementia
Jacobs, H. I. L., Wiese, S., van de Ven, V. G., Gronenschild, E. H. B. M., Verhey, F. R. J., & Matthews, P. (2014) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2014.10.041 · Cited by 89
Rüb, U., Stratmann, K., Heinsen, H., Turco, D. D., Seidel, K., den Dunnen, W. F. A., & Korf, H. (2016) · Current Alzheimer Research · doi:10.2174/1567205013666160606100509 · Cited by 81
Eldrup, E., Mogensen, P., Jacobsen, J., Pakkenberg, H., & Christensen, N. J. (2009) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.1995.tb01023.x · Cited by 80
Control of Sleep and Wakefulness in Health and Disease
Zeitzer, J. M. (2013) · Progress in molecular biology and translational science · doi:10.1016/b978-0-12-396971-2.00006-3 · Cited by 77
Aston‐Jones, G., Foote, S. L., & Segal, M. (1985) · Neuroscience · doi:10.1016/0306-4522(85)90077-6 · Cited by 77
Ear2 Deletion Causes Early Memory and Learning Deficits in APP/PS1 Mice
Kummer, M. P., Hammerschmidt, T., Martínez, A., Terwel, D., Gregor Eichele, C., Witten, A., Figura, S., Stoll, M., Schwartz, S., Pape, H., et al. (2014) · Journal of Neuroscience · doi:10.1523/jneurosci.4027-13.2014 · Cited by 73
Self-citationLocus coeruleus degeneration exacerbates olfactory deficits in APP/PS1 transgenic mice
Rey, N. L., Jardanhazi‐Kurutz, D., Terwel, D., Kummer, M. P., Jourdan, F., Didier, A., & Heneka, M. T. (2010) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2010.10.009 · Cited by 73
Pamphlett, R. (2013) · Medical Hypotheses · doi:10.1016/j.mehy.2013.11.016 · Cited by 73
Shin, E., Rogers, J. T., Devoto, P., Björklund, A., & Carta, M. (2014) · Experimental Neurology · doi:10.1016/j.expneurol.2014.04.011 · Cited by 71
Selective Vulnerability of Brainstem Nuclei in Distinct Tauopathies: A Postmortem Study
Eser, R. A., Ehrenberg, A. J., Petersen, C., Dunlop, S. R., Mejia, M. B., Suemoto, C. K., Walsh, C. M., Rajana, H., Oh, J. Y., Theofilas, P., et al. (2018) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/nlx113 · Cited by 71
Regulation of neurological and neuropsychiatric phenotypes by locus coeruleus-derived galanin
Weinshenker, D., & Holmes, P. V. (2015) · Brain Research · doi:10.1016/j.brainres.2015.11.025 · Cited by 68
Self-citationThe Proteome of the Locus Ceruleus in Parkinson's Disease: Relevance to Pathogenesis
van Dijk, K. D., Berendse, H. W., Drukarch, B., Fratantoni, S. A., Pham, T. V., Piersma, S. R., Huisman, E., Brevé, J. J. P., Groenewegen, H. J., Jiménez, C. R., et al. (2011) · Brain Pathology · doi:10.1111/j.1750-3639.2011.00540.x · Cited by 67
Selective noradrenergic vulnerability in alpha-synuclein transgenic mice
Sotiriou, E., Vassilatis, D. K., Vila, M., & Stefanis, L. (2009) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2008.11.010 · Cited by 64
Norepinephrine Protects against Amyloid-β Toxicity via TrkB
Liu, X., Ye, K., & Weinshenker, D. (2015) · Journal of Alzheimer s Disease · doi:10.3233/jad-141062 · Cited by 62
Self-citationSzot, P., Franklin, A., Miguélez, C., Wang, Y., Vidaurrazaga, I., Ugedo, L., Sikkema, C. L., Wilkinson, C. W., & Raskind, M. A. (2015) · Neuropharmacology · doi:10.1016/j.neuropharm.2015.09.003 · Cited by 62
Neurobiologic Bases of Noncognitive Behavioral Problems in Alzheimer Disease
Raskind, M. A., & Peskind, E. R. (1994) · Alzheimer Disease & Associated Disorders · doi:10.1097/00002093-199404000-00005 · Cited by 60
Down but Not Out: The Consequences of Pretangle Tau in the Locus Coeruleus
Chalermpalanupap, T., Weinshenker, D., & Rorabaugh, J. M. (2017) · Neural Plasticity · doi:10.1155/2017/7829507 · Cited by 59
Self-citationNeuroprotective Role for Galanin in Alzheimer’s Disease
Counts, S., Perez, S. E., Ginsberg, S. D., & Mufson, E. J. (2010) · Proceedings of the Fourth International Symposium on Polarization Phenomena in Nuclear Reactions · doi:10.1007/978-3-0346-0228-0_11 · Cited by 58
Miguélez, C., Aristieta, A., Cenci, M. A., & Ugedo, L. (2011) · PLoS ONE · doi:10.1371/journal.pone.0024679 · Cited by 56
Differential degeneration of the locus coeruleus in dementia subtypes
Brunnström, H., Friberg, N., Lindberg, E., & Englund, E. M. (2011) · Clinical Neuropathology · doi:10.5414/npp30104 · Cited by 54
Häidkind, R., Eller, M., Harro, M., Kask, A., Rinken, A., Oreland, L., & Harro, J. (2002) · European Neuropsychopharmacology · doi:10.1016/s0924-977x(02)00076-7 · Cited by 54
CART peptides colocalize with tyrosine hydroxylase neurons in rat locus coeruleus
Koylu, E. O., Smith, Y., Couceyro, P. R., & Kuhar, M. J. (1999) · Synapse · doi:10.1002/(sici)1098-2396(19990315)31:4<309::aid-syn10>3.0.co;2-6 · Cited by 52
Corradini, B. R., Iamashita, P., Tampellini, E., Farfel, J. M., Grinberg, L. T., & Moreira‐Filho, C. A. (2014) · BioMed Research International · doi:10.1155/2014/543673 · Cited by 43
Biomarkers, Mechanisms, and Potential Prevention of Catecholamine Neuron Loss in Parkinson Disease
Goldstein, D. S. (2013) · Advances in pharmacology · doi:10.1016/b978-0-12-411512-5.00012-9 · Cited by 35
Brain transcriptomic profiling in idiopathic and LRRK2-associated Parkinson's disease
Botta‐Orfila, T., Sánchez‐Pla, Á., Fernández, M., Carmona, F., Ezquerra, M., & Tolosa, E. S. (2012) · Brain Research · doi:10.1016/j.brainres.2012.05.036 · Cited by 34
Pérez, V., Marín, C., Rubio, A., Aguilar, E., Barbanoj, M. J., & Kulisevsky, J. (2009) · Journal of Neural Transmission · doi:10.1007/s00702-009-0291-0 · Cited by 30
Bockstaele, E. J. V., García-Hernández, F., Fox, K. M., Alvarez, V. A., & Williams, J. T. (2004) · Neurochemistry International · doi:10.1016/j.neuint.2003.08.019 · Cited by 23
Postnatal development of preproenkephalin mRNA containing neurons in the rat lower brainstem
Morita, Y., Zhang, J., Hironaka, T., et al. (1990) · The Journal of Comparative Neurology · doi:10.1002/cne.902920204 · Cited by 22
Mravec, B., Lejavová, K., Vargovič, P., Ondičová, K., Horváthová, Ľ., Novák, P., Manz, G., Filipčík, P., Novák, M., & Květňanský, R. (2016) · Journal of Neuroinflammation · doi:10.1186/s12974-016-0482-1 · Cited by 19
Gaval‐Cruz, M., Goertz, R. B., Puttick, D. J., Bowles, D. E., Meyer, R. C., Hall, R. A., Ko, D., Paladini, C. A., & Weinshenker, D. (2014) · Addiction Biology · doi:10.1111/adb.12174 · Cited by 14
Self-citationNew Pharmacological Approaches to Treating Non-Motor Symptoms of Parkinson’s Disease
Kelberman, M. A., & Vazey, E. M. (2016) · Current Pharmacology Reports · doi:10.1007/s40495-016-0071-0 · Cited by 14
Increased activity of surviving locus ceruleus neurons in Alzheimer's disease
Moser (1999) · Pure Amsterdam UMC · doi:10.1002/1531-8249(199901)45:1
Cited by
Locus coeruleus: a new look at the blue spot
Poe, G. R., Foote, S., Eschenko, O., Johansen, J. P., Bouret, S., Aston-Jones, G., Harley, C. W., Manahan-Vaughan, D., Weinshenker, D., Valentino, R., et al. (2020) · Nature Reviews Neuroscience · doi:10.1038/s41583-020-0360-9 · Cited by 720
Self-citationLiu, Y. U., Ying, Y., Li, Y., Eyo, U. B., Chen, T., Zheng, J., Umpierre, A. D., Zhu, J., Bosco, D. B., Dong, H., et al. (2019) · Nature Neuroscience · doi:10.1038/s41593-019-0511-3 · Cited by 400
Locus coeruleus imaging as a biomarker for noradrenergic dysfunction in neurodegenerative diseases
Betts, M. J., Kirilina, E., Otaduy, M. C. G., Ivanov, D., Acosta-Cabronero, J., Callaghan, M. F., Lambert, C., Cardenas-Blanco, A., Pine, K., Passamonti, L., et al. (2019) · Brain · doi:10.1093/brain/awz193 · Cited by 365
Rapid Reconfiguration of the Functional Connectome after Chemogenetic Locus Coeruleus Activation
Zerbi, V., Floriou-Servou, A., Markicevic, M., Vermeiren, Y., Sturman, O., Privitera, M., von Ziegler, L., Ferrari, K. D., Weber, B., De Deyn, P. P., et al. (2019) · Neuron · doi:10.1016/j.neuron.2019.05.034 · Cited by 317
Noradrenergic Responsiveness Supports Selective Attention across the Adult Lifespan
Dahl, M. J., Mather, M., Sander, M. C., & Werkle-Bergner, M. (2020) · The Journal of Neuroscience · doi:10.1523/jneurosci.0398-19.2020 · Cited by 72
Metadata
- Authors
- Weinshenker, D.
- Venue
- Trends in Neurosciences
- Publisher
- Elsevier BV
- Published
- 2018-04
- Volume
- 41
- Issue
- 4
- Pages
- 211-223
- ISSN
- 0166-2236 (ISSN-L)
- OpenAlex
- W2788770082
- Cited by
- 323
- References
- 141
- FWCI
- 3.76
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.